Dan Mellor

Dan Mellor is a seasoned medical affairs professional with extensive experience in oncology and haematology. Currently serving as an Executive Committee Member at Medical Affairs Professional Australasia (MAPA) and Country Medical Director for Australia and New Zealand at Antengene, Dan Mellor previously held roles at AstraZeneca, Gilead Sciences, and Roche, focusing on medical leadership and compliance. As the founder and director of Dan Mellor Consulting, Dan Mellor specializes in providing strategic solutions for pharmaceutical and biotech clients. With a PhD in Cancer Pharmacogenomics from Monash University and a background in pharmacy, Dan Mellor has contributed significant expertise in clinical research and commercialization, while also engaging in academia as a guest lecturer.